Abstract:Abstract Introduction: 25-50% of localized renal cell carcinoma (RCC) patients will eventually develop metastasis which has a dramatic adverse effect on prognosis following treatment. Unfortunately, reliable biomarkers predicting RCC metastasis are still lacking. MicroRNAs (miRNAs) are important regulators for vital biological processes in humans. Urine miRNAs(UmiRNAs) present promising potential as biomarkers for diagnosis of urological cancers. However, no study has assessed the predictive value of UmiRNAs for RCC metastasis. Materials and Methods: We prospectively collected pre- and post-surgery urine samples from 117 patients with localized clear cell RCC (ccRCC,T1-3 N0/x M0). UmiRNAs were extracted and purified from 250 μl urine supernatants and measured using RT-PCR. Relative quantifications (RQ) of 137 selected miRNAs were calculated by 2−ΔΔct method. The ratio of post/pre RQs were tested for the association with distant metastasis using multivariable Cox regression models. Results: More than half of the patients were diagnosed at pT3 (53%) or grade III-IV (69%). Twenty-two patients (18.8%) had metastasis during a mean follow-up of 73 months. The levels of 34 UmiRNAs were significantly changed after nephrectomy (p<0.05, 29 of 34 significantly reduced). The 50% or more reduced post-nephrectomy levels of five UmiRNAs (miR-191-5p, miR-324-3p, miR-186-5p, miR-93-5p, and miR-30b-5p) independently conferred a 2- to 4-fold increased risk of metastasis with miR-191-5p being the most significant one (hazard ratio [HR] = 4.16, 95% confidence interval [CI] = 1.38-12.58, p = 0.011). Stratified analyses by stage and Fuhrman grade revealed that the associations were most profound in pT3 patients for miR-191-5p, miR-324-3p, and miR-186-5p. Ingenuity pathway analysis showed that the predicted target genes of these five UmiRNAs were enriched in cell survival and proliferation networks. Conclusion: Our study suggests that urinary miR-191-5p, miR-324-3p, and miR-186-5p are potential biomarkers for the prediction of metastasis in localized, particularly pT3 ccRCC patients after nephrectomy. These findings may help improve individualized patient management in the clinic. Citation Format: Xiang Shu, Michelle AT Hildebrandt, Rodolfo Borges dos Reis, Yuanqing Ye, Jian Gu, Christopher G. Wood, Xifeng Wu. Urinary miRNAs as predictors of tumor metastasis in localized patients with clear cell renal cell carcinoma: a pilot study. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 1527.

MP85-07 URINARY MIRNAS AS A PREDICTOR OF TUMOR RECURRENCE IN PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA

RCC1 functions as a tumor facilitator in clear cell renal cell carcinoma by dysregulating cell cycle, apoptosis, and EZH2 stability

Upregulation of Serine Metabolism Enzyme PSAT1 Predicts Poor Prognosis and Promotes Proliferation, Metastasis and Drug Resistance of Clear Cell Renal Cell Carcinoma.

Microrna-191-5p Exerts A Tumor Suppressive Role In Renal Cell Carcinoma

Decreased Mir-200A-3p is a Key Regulator of Renal Carcinoma Growth and Migration by Directly Targeting CBL.

CYR61 as a potential biomarker for the preoperative identification of muscle-invasive bladder cancers

miR-184-5p inhibits cell proliferation, invasion and predicts prognosis of clear cell renal cell carcinoma by targeting NUS1 dehydrodolichyl diphosphate synthase subunit: Results from large-scale comprehensive identification and validation

Identification of Mir-130B As an Oncogene in Renal Cell Carcinoma

MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1)

Oncogenic Mir-425-5p is Associated with Cellular Migration, Proliferation and Apoptosis in Renal Cell Carcinoma

Urinary Mirnas Predict Metastasis in Patients with Clinically Localized Clear Cell Renal Cell Carcinoma Treated with Nephrectomy.

Identification of Mir-30B As an Oncogene in Renal Cell Carcinoma

MiR-1 Downregulation Correlates with Poor Survival in Clear Cell Renal Cell Carcinoma Where It Interferes with Cell Cycle Regulation and Metastasis.

The Effect of CacyBP/SIP on the Phosphorylation of ERK1/2 and p38 Kinases in Clear Cell Renal Cell Carcinoma

Development of an Individualized Ubiquitin Prognostic Signature for Clear Cell Renal Cell Carcinoma

MiR-378a-5p acts as a tumor suppressor in renal cell carcinoma and is associated with the good prognosis of patients.

Hypomethylated RRBP1 Potentiates Tumor Malignancy and Chemoresistance in Upper Tract Urothelial Carcinoma

Tumor Suppressive Mir-196A is Associated with Cellular Migration, Proliferation and Apoptosis in Renal Cell Carcinoma

Downregulation of Transmembrane Protein 40 by Mir-138-5p Suppresses Cell Proliferation and Mobility in Clear Cell Renal Cell Carcinoma.

Oncogenic microRNA-1423 p is associated with cellular migration , proliferation and apoptosis in renal cell carcinoma

Abstract 1527: Urinary Mirnas As Predictors of Tumor Metastasis in Localized Patients with Clear Cell Renal Cell Carcinoma: a Pilot Study